Tradestie Institutional Equity Comparison Engine

ACCL vs BLNE โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ACCL Overall Edge

ACCL Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ACCL (ACCL) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while BLNE counters with relative strength in Valuation. Fundamentally, ACCL trades at N/M Forward P/E with 4.5% operating margin (+11.3% YoY revenue) versus BLNE at 5.5x Forward P/E and -179.8% operating margin (+29.8% YoY). In options structure, ACCL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BLNE sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner BLNE
ACCL N/M vs BLNE 5.5x Fwd P/E
Growth & Margin Winner ACCL
Op Margin 4.5% vs -179.8% ยท YoY +11.3% vs +29.8%
Momentum & Technical Winner ACCL
1Y -43.3% vs -80.8% ยท 52W Pos 30% vs 0%
Options & Structure Winner ACCL
UNCLASSIFIED (N/A IV) vs BREAKDOWN (N/A IV)
ACCL US Equity
ACCL
Institutional Equity
$2.36
-0.42% 1D
Market Cap $33.1M
1M Return -9.92%
1Y Return -43.27%
Forward P/E N/M
Unified AI Score
64.5 / 100 BUY
Tech 66.0 Fund 56.0 Flow 50.0 Mom 50.0
BLNE NASDAQ
Beeline Holdings, Inc. Common Stock
Mortgage Bankers & Loan Correspondents
$0.29
-21.72% 1D
Market Cap $13.1M
1M Return -57.51%
1Y Return -80.81%
Forward P/E 5.5x
Unified AI Score
43.4 / 100 HOLD
Tech 25.0 Fund 42.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ACCL -43.27% BLNE -80.81% Spread: +38.94 pp (ACCL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ACCL TTM Op. Margin: 4.5% BLNE TTM Op. Margin: -179.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ACCL vs BLNE. Trailing 12-month operating profitability (ACCL 4.5% vs BLNE -179.8%) and valuation multiples (ACCL N/M vs BLNE 5.5x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ACCL (7) vs BLNE (3)
Institutional Metric ACCL BLNE Criterion Row Winner
Market Capitalization Scale $33.1M $13.1M Larger Scale ACCL
Trailing P/E Ratio Valuation 118.5x 5.5x Lower Multiple BLNE
Forward P/E Ratio Valuation N/M 5.5x Lower Multiple BLNE
Revenue Growth (YoY) Growth +11.3% +29.8% Higher Growth BLNE
Operating Margin (TTM) Profitability 4.5% -179.8% Higher Margin ACCL
Net Profit Margin Profitability 5.5% -185.9% Higher Margin ACCL
Return on Equity (ROE) Capital Efficiency 7.0% -42.4% Higher ROE ACCL
52-Week Range Position Momentum 30% ($1โ€“$5) 0% ($0โ€“$4) Stronger Trend ACCL
Beta / 30D Volatility Risk Regime -0.16ฮฒ ยท 56% Vol 2.74ฮฒ ยท 123% Vol Lower Realized Risk ACCL
Unified Institutional Score Composite Signal 64.5 / 100 (BUY) 43.4 / 100 (HOLD) Higher Composite ACCL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ACCL vs BLNE Buy Guide
ACCL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ACCL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BLNE BREAKDOWN
102d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BLNE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ACCL nor BLNE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.